scorecard
  1. Home
  2. stock market
  3. news
  4. Another IPO in July: Rolex Rings to raise ₹731 crore through public listing

Another IPO in July: Rolex Rings to raise ₹731 crore through public listing

Another IPO in July: Rolex Rings to raise ₹731 crore through public listing
  • Rolex Rings, a manufacturer and global supplier of hot rolled, forged and machined bearing rings, and automotive components for segments of vehicles is coming with initial public offering (IPO).
  • The company is looking to raise ₹731 crore through public listing from July 28 to July 30.
  • It has set a price band of ₹880-900 for the issue.
The next initial public offering (IPO) all set to hit the Indian bourses in July is of Rolex Rings, which is looking to raise ₹731 crore through the public listing.

The Rajkot-based company is a manufacturer and global supplier of forged and machined components. The firm has 3 manufacturing plants in Rajkot.

The bidding will start on July 28 and close on July 30 with a price band of ₹880 to ₹900 per share. The offer comprises a fresh issue of ₹56 crore and an offer for sale by private equity firm Rivendell PE of up to 75 lakh equity shares.

Here are the important details to note:
Issue details


Price band

₹880 to ₹900

IPO open date

July 28

IPO close date

July 30

Allotment date

August 4

Initiation of refunds

August 5

Credit of shares to demat account

August 6

IPO listing date

August 9

Minimum lot

16

Source: Company release and media reports

The company will utilise the net proceeds of the IPO towards funding long-term working capital requirements and for general corporate purposes.

Particulars

FY21

FY20

FY19

Profit

₹86 crore

₹52 crore

₹59 crore

Revenue

₹619 crore

₹675 crore

₹911 crore

Source: Red Herring Prospectus

In FY20, the company supplied bearing rings and automotive components to over 60 customers in 17 countries, primarily located in India, US and in European countries such as Germany, France, Italy, and Czech Republic, and Thailand.

SEE ALSO: BYJU's is willing to shell out 10X of what Great Learning earned during the best year for edtech

One may subscribe to Glenmark Life Sciences IPO because of clean regulatory history, strong promoter backing and good track record, say analysts

READ MORE ARTICLES ON


Popular Right Now




Advertisement